Back to CLDX
Kynam Capital Management, LP → CLDX
Kynam Capital Management, LP CLDX Position History
Celldex Therapeutics, Inc.
Quarters held
4
Latest value
$164.2M
Q3 2026
Peak value
$198.1M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $161.4M |
| Q1 2026 | $185.3M |
| Q2 2026 | $198.1M |
| Q3 2026 | $164.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $164.2M | 5.07M | — | — |
| Q2 2026 | $198.1M | 5.32M | — | — |
| Q1 2026 | $185.3M | 5.84M | — | — |
| Q4 2025 | $161.4M | 5.94M | — | — |
Other funds holding CLDX
$343.1M
$250M
$240.9M
$223.4M
$212.9M